884 results on '"Woermann B"'
Search Results
2. A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: A study of the CESAR Central European Society for Anticancer Drug Research–EWIV
3. Randomized Comparison of Sequential High-Dose Cytosine Arabinoside and Idarubicin (S-HAI) with or without Chemo-Modulation by Fludarabine in Refractory and Relapsed Acute Myeloid Leukemia
4. Multivariate Analysis of Prognostic Factors in Patients with Refractory and Relapsed Acute Myeloid Leukemia Undergoing Sequential High-Dose Cytosine Arabinoside and Mitoxantrone (S-HAM) Salvage Therapy: Significance of Cytogenetic Abnormalities
5. Modulation of AraC by Fludarabine: Results of Salvage Therapy by AMLCG
6. MLL-Duplications are Rare and Associated with Poor Prognosis in Acute Myeloid Leukemia
7. Analysis of the Apoptotic Signal Transduction Cascade and New Differentially Expressed Genes in Drug Resistant and Sensitive Hematopoetic Cell Lines
8. G-CSF Increases the Number of Trisomy 8 Metaphases in Vitro in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
9. The Prognostic Impact of Trisomy 8 in Acute Myeloid Leukemia: Do Accompanying Aberrations Influence Prognosis?
10. Hematopoietic Growth Factors: Supportive and Priming Effects in AML
11. The Karyotype in MDS — Cytogenetic Profile, Clinical Correlations and Prognostic Implications in 362 Patients with MDS
12. Failure of Fluconazole Prophylaxis to Reduce Mortality During Treatment for Refractory Acute Myeloid Leukemia: Results of a Phase III Multicenter Study
13. Detection Limits of Malignant Cells with Leukemia-Associated Phenotype (LAP) in Acute Myeloid Leukemia
14. Clonal Chromosomal Abnormalities in the Stem Cell Compartment of a Patient with Acute Myeloid Leukemia in Hematological Complete Remission
15. Granulocyte Colony-Stimulating Factor Improves the Antileukemic Efficacy of the Sequential High-Dose Cytosine Arabinoside and Mitoxantrone Regimen (S-HAM) in Patients Younger than 60 Years with High-Risk Acute Myeloid Leukemia
16. Superiority of High-Dose over Intermediate-Dose Cytosine Arabinoside (AraC) in the Treatment of Patients with High-Risk Acute Myeloid Leukemia (AML)
17. Treatment of Relapsed and Refractory Acute Myeloid Leukemias — Strategies of the German AML Cooperative Group (AMLCG)
18. All-Trans Retinoic Acid (ATRA) Combined with Double Induction Strategy in Acute Promyelocytic Leukemia (APL). Preliminary Results
19. Biologic Determinants for AML Therapy
20. Involvement of CD34+ Stem Cells in Malignant Transformation in AML and MDS — Genetic Analysis of Sorted Subpopulations by Classical and Molecular Cytogenetics
21. Functional Characterization of Leukemic Stem Cells in Acute Myeloid Leukemia
22. Growth Factors in AML: Updates
23. Fludarabine and Fludarabine, Mitoxantrone, Dexamethasone in the Management of Low-Grade Non-Hodgkin Lymphomas
24. Detection of Minimal Residual Disease in Cytogenetically Defined Prognostic Subgroups of AML
25. Correlation of Deoxycytidine Deaminase, Thymidine Kinase and Polymerase Alpha Activity and Deoxycytidine Deaminase Gene Expression In Vivo with Clinical Response to TAD-9+GM-CSF Induction Therapy in Acute Myeloid Leukemia
26. Characterization of Normal and Leukemic Lymphohematopoietic Precursor Cells by Three-Color Flow Cytometry and Detection of Clone-Specific Leukemia-Associated T-Cell Receptor δ Rearrangements
27. IFN-α Is an Inhibitory Cytokine of Leukemic B-Cell Precursors
28. Therapy of Sepsis Syndrome with Human Polyclonal IgM-Enriched Immunoglobulins: Interim Analysis of a Randomized Trial in Neutropenic Cancer Patients
29. Genetic Instability and Evolution of Karyotype in Secondary Acute Myeloid Leukemia
30. Preliminary Results of a Placebo-Controlled, Double-Blind Trial Evaluating Sequential HD-AraC/Mitoxantrone Induction Chemotherapy with or Without Granulocyte-Macrophage Colony-Stimulating Factor in Patients with High-Risk Myelodysplastic Syndromes
31. Chromosome Abnormalities and Karyotype Evolution in the Stem Cell Compartments of AML and MDS
32. The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
33. Comparison of Flask and Bag Systems in Cultivation of Dendritic Cells for Clinical Application
34. Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes
35. S-HAM Salvage Therapy of Relapsed and Refractory AML Followed by Interleukin 2 Postremission Therapy
36. Hematopoietic Recovery and Priming — Therapeutic Effects of GM-CSF in the Treatment of AML
37. Hematologic and Therapeutic Effects of High-Dose AraC/Mitoxantrone (HAM) in the Induction Treatment of Patients with Newly Diagnosed AML. A Trial by AML Cooperative Group
38. Fludarabine in Combination with Mitoxantrone and Dexamethasone in Relapsed and Refractory Low-Grade Non-Hodgkin’s Lymphoma
39. Heterogeneity of HRX-FEL Fusion Transcripts in Adult and Pediatric t(4;11) ALL
40. CD34 and CD38 Expression on Blasts in Myelodysplastic Syndromes and Secondary AML
41. Modulation of Intracellular Ara-C Metabolism in AML Blasts by GM-CSF
42. Effects on Ara-C Cytotoxicity for AML Colony Forming Cells By Priming With rhGM-CSF and rhIL-3 In Vitro and In Vivo
43. GM-CSF in Chemotherapy for Newly Diagnosed AML: Multiple Course Priming and Longterm Administration Compared to Chemotherapy Alone
44. Significance of Lineage-Associated Transcripts of TdT and ETS1 for Detection of Leukemic Cells
45. Characterization of Clonal Gene Rearrangements for the Detection of Residual Leukemic Disease in Acute Lymphoblastic Leukemia
46. Prospective Study on the Clinical Relevance of Residual Disease in Patients with Acute Myeloid Leukemia in Complete Remission
47. Chemotherapy Intensity and Long-Term Outcome in AML
48. Biology Oriented Investigation of Treatment Strategies for Acute Myeloid Leukemia (AML): The AMLCG Approach
49. FS-HAI for Relapsed AML
50. Assessment of Lymphokine-Activated Killer Activity Against Myeloid Leukemic Blasts and the Myeloid Cell Line K562 by Flow Cytometry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.